Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Pulmonary Embolism
×
30 days
×
Clear all
Filters
3
NCT05171075
2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3
Terminated
417 enrolled
NCT07410117
2026-04-09
ROXI-CAT-I
Regeneron Pharmaceuticals
Phase 3
Recruiting
860 enrolled
NCT07493304
2026-03-25
ROXI-CAT-II
Regeneron Pharmaceuticals
Phase 3
Not yet recruiting
1,600 enrolled